Skip to main content
. 1998 Jul;36(7):2023–2029. doi: 10.1128/jcm.36.7.2023-2029.1998

TABLE 3.

Comparison of CA and in-house PCR to the adapted gold standard

Specimens Amplification system No. of adapted gold standard-positive specimensa that were PCR:
No. of adapted gold standard-negative specimensb that were PCR:
Sensitivity (%) Specificity (%) NPV (%) PPV (%)
Positive Negative Positive Negative
All (n = 1,527) CA 67 34 4 1,422 66.33 99.71 97.66 94.36
In house 92 9 2 1,424 91.08 99.85 99.37 97.87
Smear positive CA 28 4 0 0 87.50 99.37
 (n = 32)c In house 31 1 0 0 96.87 99.37
Smear negative CA 39 30 4 1,422 56.52 99.71 97.93 90.69
 (n = 1,495)d In house 61 8 2 1,424 88.40 99.85 99.44 96.82
a

Specimens from patients with TB (for a definition, see Materials and Methods). 

b

Specimens from patients without any evidence of TB. 

c

Includes only specimens from TB patients. 

d

Includes six unspecific positive smears and 10 smear-positive specimens from patients infected with MOTT.